gene

OGT

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about OGT: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

145Connections
0Hypotheses
0Analyses
50Outgoing
43Incoming

Summary

Gene profile: OGT - O-GlcNAc N-acetylglucosaminyltransferase, the enzyme that adds O-GlcNAc to proteins, central to O-GlcNAcylation cycling

View on Wiki →

🧬 Gene Info
Gene SymbolOGT
Full NameO-GlcNAc N-acetylglucosaminyltransferase
AliasesGene profile: OGT
ChromosomeXq13.1
FunctionOGT catalyzes the transfer of a single GlcNAc from UDP-GlcNAc to the hydroxyl group of serine and threonine residues on target proteins
Primary Expressionneurons and glia:
Molecular Weight~110 kDa (nuclear isoform)
Amino Acids016 aa
PathwaysApoptosis, Autophagy, Glycolysis, Immune Response, Inflammasome
UniProt IDO15294
GeneCardsOGT
Human Protein AtlasOGT
Protein ProductOGT (O-GlcNAc Transferase)
EC Number2.4.1.255
Alternative NamesOGT, O-linked N-acetylglucosamine transferase, HRMT1L2 (hexosamine-1,4-N-acetylglucosaminyl transferase)
Associated Diseasesdepression, neurodegeneration
Known Drugs/CompoundsROS
InteractionsSLC7A11, ULK1, RIPK3, RIPK1, APP, STX17
KG Connections145 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING
🔮 Predicted Structure: OGT — AlphaFold O15294 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

OGT — O-GlcNAc Transferase

gene · 1429 words

Niemann-Pick Disease Type C (NPC)

disease · 4341 words

O-GlcNAcase (OGA) Inhibitor Landscape — Programs, Mechanisms, Companies

therapeutic · 3763 words

FNP-223 PROSPER Trial - Phase 2 in Progressive Supranuclear Palsy

clinical · 3559 words

Protein O-GlcNAcylation Pathway in Neurodegeneration

mechanism · 3298 words

oga-inhibition-tau

mechanism · 2692 words

Pathway Diagram

graph TD
    OGT["<b>OGT</b>"]
    Carcinoma{"Carcinoma"}
    OGT -->|"contributes to"| Carcinoma
    Ms{"Ms"}
    OGT -->|"activates"| Ms
    Tumor{"Tumor"}
    OGT -->|"contributes to"| Tumor
    OGT -->|"activates"| Carcinoma
    Cancer{"Cancer"}
    OGT -->|"activates"| Cancer
    Als{"Als"}
    OGT -->|"activates"| Als
    OGT -->|"regulates"| Als
    Inflammation{"Inflammation"}
    OGT -->|"activates"| Inflammation
    OGT -->|"regulates"| Ms
    Depression{"Depression"}
    OGT -->|"activates"| Depression
    FOXK2["FOXK2"]
    OGT -->|"regulates"| FOXK2
    HCC{"HCC"}
    OGT -->|"contributes to"| HCC
    ROS["ROS"]
    ROS -->|"activates"| OGT
    SLC7A11["SLC7A11"]
    SLC7A11 -->|"activates"| OGT
    STX17["STX17"]
    STX17 -->|"activates"| OGT
    FOXK2 -->|"activates"| OGT
    ULK1["ULK1"]
    ULK1 -->|"activates"| OGT
    FERROPTOSIS["FERROPTOSIS"]
    FERROPTOSIS -->|"associated with"| OGT
    ENO1["ENO1"]
    ENO1 -->|"regulates"| OGT
    TLR["TLR"]
    TLR -->|"regulates"| OGT
    EXOSOMES["EXOSOMES"]
    EXOSOMES -->|"regulates"| OGT
    TRAF6["TRAF6"]
    TRAF6 -->|"regulates"| OGT
    ASTROCYTES["ASTROCYTES"]
    ASTROCYTES -->|"regulates"| OGT
    ASTROCYTE["ASTROCYTE"]
    ASTROCYTE -->|"regulates"| OGT
    style OGT fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (102)

TargetRelationTypeStr
FOXK2O-GlcNAcylatesprotein0.90
DEPRESSIONbiomarker_fordisease0.80
Neurodegenerationactivatesdisease0.75
Alzheimeractivatesdisease0.75
Autophagyactivatespathway0.70

Incoming (43)

SourceRelationTypeStr
ROSactivatesdrug0.72
NEURODEGENERATIONactivatesgene0.70
ALZHEIMERactivatesgene0.70
SLC7A11activatesgene0.60
STX17activatesgene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found